Filter by: Subject
Now showing items 1-6 of 2
Análisis costo-beneficio (2) |
Colitis ulcerosa (2) |
Eficacia (2) |
Infliximab (2) |
Adalimumab (1) |
Factor de necrosis tumoral alfa (1) |
Análisis costo-beneficio (2) |
Colitis ulcerosa (2) |
Eficacia (2) |
Infliximab (2) |
Adalimumab (1) |
Factor de necrosis tumoral alfa (1) |